Cargando…
sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation
BACKGROUND: Pathogenetic mechanisms of the progression of NAFL to advanced NASH coupled with potential noninvasive biomarkers and novel therapeutic targets are active areas of investigation. The recent finding that increased plasma levels of a protein shed by myeloid cells —soluble Triggering Recept...
Autores principales: | Kothari, Vishal, Savard, Christopher, Tang, Jingjing, Lee, Sum P., Subramanian, Savitha, Wang, Shari, den Hartigh, Laura J., Bornfeldt, Karin E., Ioannou, George N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578746/ https://www.ncbi.nlm.nih.gov/pubmed/37820278 http://dx.doi.org/10.1097/HC9.0000000000000265 |
Ejemplares similares
-
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023) -
sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021) -
sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology
por: Nabizadeh, Fardin
Publicado: (2023) -
The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
por: Ferri, Evelyn, et al.
Publicado: (2021) -
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
por: Ewers, Michael, et al.
Publicado: (2020)